Bronica tablets 80 mg for bronchial asthma (seratrodast)
Product Code :
Availability : 16
General information on Japanese Bronica tablets 80 mg for bronchial asthma (seratrodast)
Package details: 100 tablets
Manufacturer: Teva Takeda Yakuhin Ltd., Japan
Active ingredient: seratrodast (chemical formula C22H26O4)
Medical effect: Bronica tablets are effective for the treatment of bronchial asthma.
Contraindications and precautions: do not use for the pregnant and breastfeeding women. Do not use in patients with hepatic disorder.
If an allergic reaction occurs, stop taking the medicine and consult with your doctor. If you’re taking any other medication, please consult with your doctor before use.
Dosage and administration of Bronica tablets 80 mg from Japan for bronchial asthma (seratrodast)
For adults, take 1 tablet (80 mg of active ingredient) 1 time a day after a dinner. Elderly patients may start from 0.5 tablet a day (40 mg of active ingredient).
How effective are Bronica tablets 80 mg from Japan for bronchial asthma (seratrodast)?
Bronica tablets contain seratrodast, a thromboxane A2 (TXA2) receptor antagonist. By suppressing thromboxane, these medicine helps to relieve the following symptoms and conditions:
- mucous secretion,
- airway hyper-responsiveness.
As the result, Bronica tablets effectively suppress development of an attack and symptoms of bronchial asthma. It is generally safe, well-tolerated medicine with few side effects (S. Terao, M. Shiraishi et al. “Thromboxane A2 Antagonist : Discovery of Seratrodast”. In Japanese language. Yakugaku Zasshi, 1999, Vol. 119, Issue 5, Pages 377-390). However, it is not designed to relieve the attack immediately.
Who should take Bronica tablets 80 mg from Japan?
Bronica tablets are recommended as a controller medication for the adult patients with mild to moderate asthma. They improve such symptoms as wheezing, shortness of breath, expectoration, cough and chest tightness and provide reduction in mucociliary parameters. Also, Bronica tablets can be used for the elderly patients, with the recuse of dosage if needed.